Vitamin D exposure and cancer incidence and mortality, all-cause mortality, and cause-specific mortality in the European Prospective Investigation into Cancer and Nutrition (EPIC)

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  2013-09-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.25560/23895
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Vitamin D, season, and risk of prostate cancer: a nested case-control study within Norwegian health studies.

  2013cited by this paper
• Serum 25-Hydroxyvitamin D and Cancer Risk in Older Adults: Results from a Large German Prospective Cohort Study

  2013cited by this paper
• Predicted plasma 25‐hydroxyvitamin D and risk of renal cell cancer

  2013cited by this paper
• A prospective study of serum 25-hydroxyvitamin d levels and mortality among African Americans and non-African Americans.

  2013cited by this paper
• Is a cancer diagnosis a trigger for health behaviour change? Findings from a prospective, population-based study

  2013cited by this paper
• Vitamin D status and skin cancer risk independent of time outdoors: 11-year prospective study in an Australian community.

  2013cited by this paper
• Vitamin D and risk of death from vascular and non-vascular causes in the Whitehall study and meta-analyses of 12,000 deaths.

  2013cited by this paper
• Prospective analysis of vitamin D and endometrial cancer risk.

  2013cited by this paper
• Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study.

  2013cited by this paper
• Plasma 25-hydroxyvitamin D concentration and lymphoma risk: results of the European Prospective Investigation into Cancer and Nutrition.

  2013cited by this paper
• Genetic Predictors of Circulating 25-Hydroxyvitamin D and Risk of Colorectal Cancer

  2013cited by this paper
• Body mass index, physical activity, and colorectal cancer by anatomical subsites: a systematic review and meta-analysis of cohort studies

  2013cited by this paper
• Vitamin D metabolism, functions and needs: from science to health claims

  2013cited by this paper
• Fruit and vegetable intake and risk of breast cancer by hormone receptor status.

  2013cited by this paper
• Plasma 25‐hydroxyvitamin D and the risk of breast cancer in the European prospective investigation into cancer and nutrition: A nested case–control study

  2013cited by this paper
• Vitamin D Status and Cause-Specific Mortality: A General Population Study

  2012cited by this paper
• Serum Vitamin D and Risk of Bladder Cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial

  2012cited by this paper
• Dietary Fibre Intake and Risks of Cancers of the Colon and Rectum in the European Prospective Investigation into Cancer and Nutrition (EPIC)

  2012cited by this paper
• Pre-Diagnostic Plasma 25-Hydroxyvitamin D Levels and Risk of Non-Melanoma Skin Cancer in Women

  2012cited by this paper
• The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease.

  2012cited by this paper
• A reverse J-shaped association of all-cause mortality with serum 25-hydroxyvitamin D in general practice: the CopD study.

  2012cited by this paper
• Pre-Diagnostic Circulating Vitamin D and Risk of Melanoma in Men

  2012cited by this paper
• Associations of circulating 25‐hydroxyvitamin D with prostate cancer diagnosis, stage and grade

  2012cited by this paper
• Determinants of plasma 25-hydroxyvitamin D and development of prediction models in three US cohorts – CORRIGENDUM

  2012cited by this paper
• Predictors of 25-hydroxyvitamin D and its association with risk factors for prostate cancer: evidence from the Prostate testing for cancer and Treatment study

  2012cited by this paper
• Serum 25-hydroxyvitamin D, vitamin A, and lung cancer mortality in the US population: a potential nutrient–nutrient interaction

  2012cited by this paper
• Instrumental Variable Estimation of the Causal Effect of Plasma 25-Hydroxy-Vitamin D on Colorectal Cancer Risk: A Mendelian Randomization Analysis

  2012cited by this paper
• Association of 25‐hydroxyvitamin D levels with liver dysfunction and mortality in chronic liver disease

  2012cited by this paper
• Serum 25-Hydroxy Vitamin D and Prostate Cancer Risk in a Large Nested Case–Control Study

  2011cited by this paper
• Association of serum 25-hydroxyvitamin D with the risk of death in a general older population in Finland

  2011cited by this paper
• Circulating Levels of Vitamin D and Colon and Rectal Cancer: The Physicians' Health Study and a Meta-analysis of Prospective Studies

  2011cited by this paper
• Plasma 25-hydroxyvitamin D and risk of breast cancer in the Nurses' Health Study II

  2011cited by this paper
• Serum 25-Hydroxyvitamin D and Risk of Lung Cancer in Male Smokers: A Nested Case-Control Study

  2011cited by this paper
• Associations of circulating and dietary vitamin D with prostate cancer risk: a systematic review and dose–response meta-analysis

  2011cited by this paper
• Meta-analysis: Circulating vitamin D and ovarian cancer risk.

  2011cited by this paper
• Vitamin D and breast cancer recurrence in the Women's Healthy Eating and Living (WHEL) Study.

  2011cited by this paper
• Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study

  2011cited by this paper
• Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)₂vitamin D₃: genomic and non-genomic mechanisms.

  2011cited by this paper
• Serum 25-hydroxyvitamin D and prevention of breast cancer: pooled analysis.

  2011cited by this paper
• Prospective association of vitamin D concentrations with mortality in postmenopausal women: results from the Women's Health Initiative (WHI).

  2011cited by this paper
• Vitamin D deficiency in cirrhosis relates to liver dysfunction rather than aetiology.

  2011cited by this paper
• Serum 25-hydroxyvitamin D and risks of colon and rectal cancer in Finnish men.

  2011cited by this paper
• Risk models and scores for type 2 diabetes: systematic review

  2011cited by this paper
• Circulating 25-Hydroxyvitamin D and Risk of Kidney Cancer

  2010cited by this paper
• CEBP Focus: Biomarkers and Biospecimens

  2010cited by this paper
• Circulating 25-Hydroxyvitamin D and Risk of Non-Hodgkin Lymphoma

  2010cited by this paper
• Predicted 25-hydroxyvitamin D score and incident type 2 diabetes in the Framingham Offspring Study.

  2010cited by this paper
• Serum 25-OH vitamin D levels and risk of developing prostate cancer in older men

  2010cited by this paper
• Body Mass Index, Hormone Replacement Therapy, and Endometrial Cancer Risk: A Meta-Analysis

  2010cited by this paper
• Circulating 25-Hydroxyvitamin D and Risk of Pancreatic Cancer

  2010cited by this paper
• Socioeconomic position and participation in colorectal cancer screening

  2010cited by this paper
• Serum 25(OH) Vitamin D and Risk of Breast Cancer: A Nested Case-Control Study from the French E3N Cohort

  2010cited by this paper
• Plasma vitamin D and mortality in older men: a community-based prospective cohort study.

  2010cited by this paper
• Vitamin D: modulator of the immune system.

  2010cited by this paper
• Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study

  2010cited by this paper
• Predicted vitamin D status and pancreatic cancer risk in two prospective cohort studies

  2010cited by this paper
• Membrane localization, Caveolin-3 association and rapid actions of vitamin D receptor in cardiac myocytes.

  2010cited by this paper
• A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution.

  2010cited by this paper
• Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon‐based therapy in genotype 1 chronic hepatitis C

  2010cited by this paper
• Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men.

  2010cited by this paper
• Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988-2006).

  2010cited by this paper
• Epidemiology of vitamin D and colorectal cancer: casual or causal link?

  2010cited by this paper
• Low serum 25-hydroxyvitamin D levels are associated with increased all-cause mortality risk in a general population: the Tromsø study.

  2010cited by this paper
• Determinants of serum 25 hydroxyvitamin D levels in a nationwide cohort of blacks and non-Hispanic whites

  2010cited by this paper
• Circulating 25-Hydroxyvitamin D and Risk of Esophageal and Gastric Cancer

  2010cited by this paper
• Plasma 25-Hydroxyvitamin D Levels and the Risk of Colorectal Cancer: The Multiethnic Cohort Study

  2010cited by this paper
• Reproducibility of Plasma, Red Blood Cell, and Urine Biomarkers among Premenopausal and Postmenopausal Women from the Nurses' Health Studies

  2010cited by this paper
• Predictors of serum 25-hydroxyvitamin D concentrations among postmenopausal women: the Women's Health Initiative Calcium plus Vitamin D clinical trial.

  2010cited by this paper
• Vitamin D insufficiency and health outcomes over 5 y in older women.

  2010cited by this paper
• Serum Vitamin D and Risk of Bladder Cancer

  2010cited by this paper
• Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer

  2010cited by this paper
• Serum vitamin D levels and survival of patients with colorectal cancer: Post-hoc analysis of a prospective cohort study

  2010cited by this paper
• Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults

  2009cited by this paper
• The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature.

  2009cited by this paper
• Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene

  2009cited by this paper
• Physical activity and colon cancer prevention: a meta-analysis

  2009cited by this paper
• Association between Plasma 25-Hydroxyvitamin D and Breast Cancer Risk

  2009cited by this paper
• Serum Vitamin D and Risk of Prostate Cancer in a Case-Control Analysis Nested Within the European Prospective Investigation into Cancer and Nutrition (EPIC)

  2009cited by this paper
• Circulating Vitamin D and Risk of Epithelial Ovarian Cancer

  2009cited by this paper
• Circulating calcitriol concentrations and total mortality.

  2009cited by this paper
• Serum 25-hydroxyvitamin D concentrations and postmenopausal breast cancer risk: a nested case control study in the Cancer Prevention Study-II Nutrition Cohort

  2009cited by this paper
• Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial.

  2009cited by this paper
• Inverse association between serum 25(OH) vitamin D levels and non-melanoma skin cancer in elderly men

  2009cited by this paper
• Association between serum 25(OH)D and death from prostate cancer

  2009cited by this paper
• Vitamin D and mortality in older men and women

  2009cited by this paper
• Vitamin D gene pathway polymorphisms and risk of colorectal, breast, and prostate cancer.

  2009cited by this paper
• Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer.

  2009cited by this paper
• Use of dietary supplements in the European Prospective Investigation into Cancer and Nutrition calibration study

  2009cited by this paper
• Reduced Prediagnostic 25-Hydroxyvitamin D Levels in Women with Breast Cancer: A Nested Case-Control Study

  2009cited by this paper
• Prospective Study of Serum 25‐Hydroxyvitamin D Level, Cardiovascular Disease Mortality, and All‐Cause Mortality in Older U.S. Adults

  2009cited by this paper
• Plasma 25‐hydroxyvitamin D and premenopausal breast cancer risk in a German case‐control study

  2009cited by this paper
• Vitamin D status in gastrointestinal and liver disease

  2008cited by this paper
• Vitamin D Status and the Risk of Lung Cancer: A Cohort Study in Finland

  2008cited by this paper
• From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health.

  2008cited by this paper
• Serum vitamin D concentration and prostate cancer risk: a nested case-control study.

  2008cited by this paper
• Etiologic heterogeneity among non-Hodgkin lymphoma subtypes.

  2008cited by this paper
• Current micronutrient recommendations in Europe: towards understanding their differences and similarities

  2008cited by this paper
• Low Serum Levels of 25-Hydroxyvitamin D Predict Fatal Cancer in Patients Referred to Coronary Angiography

  2008cited by this paper
• Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality.

  2008cited by this paper
• Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography.

  2008cited by this paper

• No citing papers are available for this paper.